$100M ESVCLP Fund

We go beyond just investing; we fund the technology to benefit people and the planet.

Read below to find out more about us, or find out how we invest.

Grey Innovation Ventures

Authorised representative 1283807 of Australian Financial Services License 334 906

With a $100M Early Stage Venture Capital Limited Partnership (ESVCLP), Grey Innovation Investment Partners (the Manager) is decreasing the traditional risk of the ESVCLP model by investing in sophisticated startup companies. With first market access to Grey Innovation Group's suite of companies in, or approaching early revenue stage, the risk is significantly reduced.

As an ESVCLP fund, we are uniquely positioned to generate significant tax credits and savings. Unprecedented government funding of over $23 billion is available for the sectors aligning with our portfolio and mandate.

 

Downloads

INFORMATION MEMORANDUM

PRESENTATION

The Structure

Investors

Limited Partners

Manager

Grey Innovation Investment Partners PTY LTD

 

  • Management team track record of delivering > 20% internal rate of return for investors
  • Full access to all Grey Innovation Group resources
  • 43.5% R&D cash rebate for Fund

Fees

  • Management fee: 1.5% (years 1-5) 1% of invested capital (less investments written down to zero) thereafter
  • 8% preferred return
  • 20% carry
  • Establishment fee (up to $300k)

The Fund

Grey Innovation Ventures Early Stage Venture Capital Limited Partnership (ESVCLP)

  • No capital gains tax
  • Projected internal rate of return > 20%
  • Immediate 10% write off
  • Size $100M
  • Term 10 Years (with potential to extend by 3 years)

Portfolio Companies

 

  • Up to 13 investments of ~$7-10M each
  • Targeted sectors: Cleantech, Medtech
  • Australian private company deal flow

First market access to Grey Innovation Group start-ups with:

  • unique skills base, repeatable start-up processors
  • discounted product development and commercialisation
  • proven track record
  • discounted service fees and license fees
  • access to a first class international network
TALi Firefly Greyscan Eco Detection Notus Canopy Blue Track Alert Systems

People

Investment Partners

All Board Executive

Organisational Chart

GIV Org Chart

Now is our time

Unprecedented funding aligns with our portfolio mandate.

$1.9 billion

Australian Renewable Energy Agency (ARENA) and Clean Energy Finance Corporation (CEFC) to fund low emission technologies.

$300 million

Advancing Hydrogen Fund (Federal Government) (run by the CEFC)

$1.3 billion

The Manufacturing Translation and Integration Streams aims to help manufacturers translate good ideas into commercial outcomes. This forms part of the Modern Manufacturing Initiative (MMI).

$20 billion

Medical Research Future Fund (Federal Government)

Plus, many more millions in ongoing grants for Cleantech and Medtech.

R&D Tax Incentive – 43.5% credits on research and development.

Partners

Research Institute Global & Channel Partners

National Health and Medical Research Council
Monash Vision Group
Charles Sturt University
HP Invent
PMHC
Global Kinetics
Cochlear
Nanosonics
Australian Research Council
Intel
Siemens
Monash University
Fraunhofer
DZNE
ResMed
Peter Mac
Eastern Health
University of Melbourne
Department of the Prime Minister and Cabinet
St Vincents Hospital
The Alfred Hospital
TMS
UTAS
Royal Eye and Ear Hospital
IBM
CSIRO
Bosch
Australian National University
Swinbourne
State Government of Victoria
Telstra Eureka